首页 | 本学科首页   官方微博 | 高级检索  
     检索      

HDAC对接研究:苯甲酰胺类抑制剂结合方式推测
引用本文:谢爱华,李伯玉,廖晨钟,李志斌,鲁先平,石乐明,周家驹.HDAC对接研究:苯甲酰胺类抑制剂结合方式推测[J].物理化学学报,2004,20(6):569-572.
作者姓名:谢爱华  李伯玉  廖晨钟  李志斌  鲁先平  石乐明  周家驹
作者单位:Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100080;1.Chipscreen Biosciences, Limited, Shenzhen 518057
基金项目:国家高技术研究发展规划(863)基金(2002AA234041,2002AA234021,2002AA104270)资助项目~~
摘    要:通过计算机模拟的对接过程研究,发现了MS-275— 一种苯甲酰胺类的组蛋白去乙酰酶(HDAC)抑制剂与酶的可能的全新结合方式.这种结合方式与已经阐明的组蛋白去乙酰酶类似蛋白(HDLP)与曲古柳菌素A(trichostatin A, TSA)和suberoylanilide hydroxamic acid(SAHA)形成的复合物晶体结构中配体与酶的作用方式完全不同.从对接结果看,MS-275的作用靶点在酶活性口袋的最狭窄部位,而不是直接作用于锌离子.这似乎能够解释MS-275的低毒性特点,并且为设计和筛选全新的HDAC抑制剂提供了新思路.

关 键 词:组蛋白去乙酰酶(HDAC)  组蛋白去乙酰酶类似蛋白(HDLP)  曲古柳菌素A(TSA)  对接  MS-275  
收稿时间:2004-02-24
修稿时间:2004-03-23

Docking Study of HDAC Implication for Benzamide Inhibitors Binding Mode
Abstract.Docking Study of HDAC Implication for Benzamide Inhibitors Binding Mode[J].Acta Physico-Chimica Sinica,2004,20(6):569-572.
Authors:Abstract
Institution:Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100080;1.Chipscreen Biosciences, Limited, Shenzhen 518057
Abstract:The paper proposed a possible binding mode of MS-275, a benzamide histone deacetylase(HDAC) inhibitor, to HDAC by intensive docking study. This binding mode is different from those observed in the crystal structure of complexes formed by a histone deacetylase-like protein (HDLP) with trichostatin A(TSA) or suberoylanilide hydroxamic acid (SAHA). The docking result implicates that the main target of MS-275 is the narrowest part of HDAC active pocket. It seems to be able to explain the low toxicity of MS-275 and provides new insights on the design of novel HDAC inhibitors.
Keywords:Histone deacetylase(HDAC)  Histone deacetylase like protein(HDLP)  Trichostatin A(TSA)  Docking  MS-275
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《物理化学学报》浏览原始摘要信息
点击此处可从《物理化学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号